Spleen cells from BALB/c mice immunized with heat-killed rough pneumococci (strain R36A) or spleen cells from normal mice immunized in vitro with the same antigen produce direct hemolytic plaques against sheep erythrocytes coated with pneumococcal C polysaccharide or conjugated with phosphorylcholine. Formation of plaques is specifically inhibited by phosphorylcholine or by antiserum to mouse immunoglobulin A myeloma protein which binds phosphorylcholine. Thus, the myeloma proteins and normal BALB/c antibodies share similar idiotypic determinants. This experimental system is suitable for probing the role of the antigen receptor in the immune response.
The anti-PC antibodies of BALB/c origin bear predominantly the idiotype characteristic of the phosphorylcholine (PC)-binding T15 idiotype than sera from adult mice, and, unlike the latter, they also contain detectable amounts of anti-T15 antibodies. By 2 weeks of age the anti-T15 antibodies are no longer detectable while the T15 idiotype has reached adult levels. Injection of neonatal mice with anti-idiotypic antibodies renders them unresponsive to PC until the 15th week of life. Furthermore, this treatment induces a chronic suppression of the T15 idiotype, since on recovery from unresponsiveness, the neonatally suppressed mice produce anti-PC antibodies which are predominantly T15-negative. In contrast, treatment of adult mice with anti-idiotypic antibodies induces only a transient state of unresponsiveness to PC, and the antibodies produced upon recovery bear the T15 idiotype. These findings are discussed in the context of idiotype anti-idiotype interactions and their possible role in immuno-regulation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.